ESR1 and cancer: Although designed to reduce ERα-mediated signals on the tumor cells themselves, it is now clear that multiple relevant cell types are estrogen-responsive, including immune cell subpopulations, cancer-associated fibroblasts, and endothelial cells, both in the local tumor microenvironment (TME) and elsewhere.